Search clinical trials for: Tarceva (OSI-774)

Total 1832 results

Istanbul Medeniyet University

Completed

Turkish Validation and Reliability of LURN SI-29 Questionnaire in Patients With Lower Urinary Tract Symptoms

Lower Urinary Tract Symptoms | Urinary Incontinence

Turkey
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center

Active, not recruiting

Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors

Leptomeningeal Metastases

United States
Centre Hospitalier Régional Metz-Thionville

Completed

Meaning of Life Questionnaire (MLQ) in Patients Admitted to the Crisis Centre (MSVCAC) (MSVCAC)

Suicide | Questionnaire | Mental Suffering | Meaning of Life

France
University of Aarhus

Completed

The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin

Insulin Resistance | Hypopituitarism | Metabolism

Denmark
McMaster University

Unknown

The Effect of Biannual Monitoring With Magnetic Resonance Imaging (MRI), X-ray, or Usual Care on Treatment for Inflammatory Arthritis (MRx)

Inflammatory Arthritis

Canada
National Cancer Institute (NCI)
United Therapeutics

Completed

Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma

Recurrent Neuroblastoma | Ganglioneuroblastoma

United States, Canada, Australia, New Zealand, Puerto Rico
Zagazig University

Recruiting

Transversus Thoracis Plane Block Versus Parasternal Intercostal Nerve Plane Block for Cardiac Surgery

Cardiac Surgery

Egypt
Kodiak Sciences Inc

Terminated

A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration. (DAZZLE)

Wet Macular Degeneration

Germany, United States, Latvia, Spain, Czechia, Poland, Slovakia
Gilead Sciences

Completed

Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection (NEUTRINO)

Chronic Hepatitis C

United States, Puerto Rico
OHSU Knight Cancer Institute
Genentech, Inc.; OSI Pharmaceuticals

Terminated

Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)

Metastatic Colorectal Cancer

United States
Intercept Pharmaceuticals

Completed

Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (REVERSE)

Nonalcoholic Steatohepatitis | Compensated Cirrhosis

United States, Spain, France, Australia, New Zealand, Puerto Rico, Germany, Canada, United Kingdom, Hungary, Poland, Ukraine
Baxter Healthcare Corporation

Terminated

Intravenous (IV) Solutions for Dehydration in Children With Gastroenteritis

Gastroenteritis | Dehydration

United States, Canada
Sheppard Pratt Health System
Central Michigan University

Withdrawn

Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study

1. Major Depressive Disorder

United States
Charite University, Berlin, Germany
Pfizer

Unknown

Temsirolimus in Recurrent Primary Central Nervous System (CNS) Lymphoma

Recurrent or Refractory Primary CNS Lymphoma

Germany
The University of Texas Health Science Center,...

Completed

Robotic Versus Laparoscopic Ventral Hernia Repair

Hernia, Ventral

United States
GlaxoSmithKline

Completed

Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528

Parkinson Disease

China
Sanofi

Completed

A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian Cancer

Ovarian Cancer

United States
Spanish Lung Cancer Group

Completed

Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced Adenocarcinoma (SLAT)

Non-small Cell Lung Cancer

Spain
Daping Hospital and the Research Institute of Surgery...

Not yet recruiting

Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)

EGFR T790M | Non-small Cell Lung Cancer Stage IV | Non-Small Cell Lung Cancer Stage IIIB
Sanofi

Completed

Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma

Glioblastoma

United States
Gilead Sciences

Completed

Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon (POSITRON)

Chronic Hepatitis C

United States, Canada, New Zealand, Puerto Rico, Australia
Qilu Hospital of Shandong University

Unknown

Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer (TCL-1)

Non-Small-Cell Lung Cancer

China
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma

Melanoma

United States
NYU Langone Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Completed

Safety of Estrogens in Lupus: Birth Control Pills

Systemic Lupus Erythematosus

United States
National Cheng Kung University
Buddhist Tzu Chi General Hospital; E-DA Hospital; Tzu Chi University

Not yet recruiting

Effects of Jing Si Herbal Tea on Quality of Life and Sleep in Dementia and Their Caregivers

Quality of Life | Dementia | Caregiver Burden
ViiV Healthcare

Active, not recruiting

A Study Evaluating Implementation Strategies for the Delivery of Cabotegravir in Low and High-Volume PrEP Site in the United States (PILLAR)

HIV Infections

United States
Universita degli Studi di Catania
Laboratory for Health Protection Research

Completed

Pharmacokinetic Profile of Toxic Substances and Nicotine in Electronic Cigarettes (KINECIG)

Tobacco Abuse Smoke

Italy
Vanderbilt University Medical Center

Completed

Balanced Solutions and Plasma Electrolytes (BASE)

Critical Illness | Acidosis, Metabolic

United States
PHARMENTERPRISES LLC

Completed

XC8 Safety, Tolerability and Pharmacokinetics in Healthy Volunteers

Asthma

Russian Federation
Gilead Sciences

Approved for marketing

Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C

Post-transplant Hepatitis C
National Cancer Institute (NCI)

Completed

CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer

Clear Cell Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer

United States
Shirley Ryan AbilityLab
Northwestern University; Northwestern Memorial Hospital

Recruiting

Powered Prosthesis for Use With TF Osseointegration Recipients

Amputation

United States
Jazz Pharmaceuticals

Terminated

Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome (ARCH)

Rett Syndrome | RTT

United States, Spain, Italy, United Kingdom
The Baruch Padeh Medical Center, Poriya

Terminated

Reduced Infant Response To A Routine Care Procedure After Glucose 25% Analgesia

Infant | Newborn Diseases
Puma Biotechnology, Inc.

Completed

Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid Tumors

Neoplasms | Malignant Carcinoma

United States, France
National Cancer Institute (NCI)

Completed

Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery

Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma | Recurrent Cervical Carcinoma | Stage IVA Cervical Cancer | Stage IVB Cervical Cancer | Stage IIIA Cervical Cancer | Stage IIIB Cervical Cancer

Canada
Vertex Pharmaceuticals Incorporated

Completed

A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)

Cystic Fibrosis

United States, Spain, United Kingdom, New Zealand, Israel, Australia, Ireland, Germany, Sweden, Czechia, Portugal, Hungary
Guangdong Association of Clinical Trials

Recruiting

Bevacizumab Plus EGFR-TKIs in Chinese Patients With EGFR-mutant NSCLC: a Real-world Study (BELLA)

NSCLC

China
Spanish Lung Cancer Group

Completed

Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR (EURTAC)

Non-Small Cell Lung Cancer

Spain, France, Italy
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site

Carcinoma

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site

Neoplasm, Unknown Primary

United States
Ashutosh Kumar Tewari
Oncovir, Inc.

Recruiting

Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance

Prostate Cancer Patients on Active Surveillance

United States
University of Pittsburgh
OSI Pharmaceuticals

Completed

Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma

United States
Finnish Lung Cancer Group
Roche Pharma AG

Completed

Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC

Non-small Cell Lung Cancer

Finland
Massachusetts General Hospital
Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Genentech...

Completed

Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer

Pancreatic Cancer | Adenocarcinoma of the Pancreas

United States
University of Cologne

Completed

Molecular Imaging With Erlotinib and Bevacizumab (MIMEB)

Non-Small-Cell Lung Carcinoma

Germany
Hoffmann-La Roche

Completed

A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis

Non-Small Cell Lung Cancer

France
Biosense Webster, Inc.

Active, not recruiting

A Study of Multi-electrode Circular Irreversible Electroporation (IRE) Catheter and Multi-Channel IRE Generator in Paroxysmal Atrial Fibrillation (AF) (AFIRE)

Refractory Paroxysmal Atrial Fibrillation

China
University Health Network, Toronto
Novartis

Completed

Study Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Prevention of Acute Rejection and Bronchiolitis Obliterans in Lung Transplant

Emphysema | COPD | Alpha-1 Antitrypsan Deficiency

Canada
Dow University of Health Sciences
Higher Education Commission (Pakistan)

Completed

Glycemic Control in T2DM Through Non-Surgical Periodontal Therapy

Type 2 Diabetes Mellitus | Chronic Periodontitis

Pakistan

Search clinical trials for: Tarceva (OSI-774)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations